Predicting Risk of Type 2 Diabetes Mellitus with Genetic Risk Models on the Basis of Established Genome-wide Association Markers: a Systematic Review

Overview

Journal Am J Epidemiol

Publisher Oxford University Press

Specialty Public Health

Date 2013 Sep 7

PMID 24008910

Citations 26

Authors

Wei Bao

Frank B Hu

Shuang Rong

Ying Rong

Katherine Bowers

Enrique F Schisterman

Liegang Liu

Cuilin Zhang

Affiliations

Soon will be listed here.

Abstract

This study aimed to evaluate the predictive performance of genetic risk models based on risk loci identified and/or confirmed in genome-wide association studies for type 2 diabetes mellitus. A systematic literature search was conducted in the PubMed/MEDLINE and EMBASE databases through April 13, 2012, and published data relevant to the prediction of type 2 diabetes based on genome-wide association marker-based risk models (GRMs) were included. Of the 1,234 potentially relevant articles, 21 articles representing 23 studies were eligible for inclusion. The median area under the receiver operating characteristic curve (AUC) among eligible studies was 0.60 (range, 0.55-0.68), which did not differ appreciably by study design, sample size, participants' race/ethnicity, or the number of genetic markers included in the GRMs. In addition, the AUCs for type 2 diabetes did not improve appreciably with the addition of genetic markers into conventional risk factor-based models (median AUC, 0.79 (range, 0.63-0.91) vs. median AUC, 0.78 (range, 0.63-0.90), respectively). A limited number of included studies used reclassification measures and yielded inconsistent results. In conclusion, GRMs showed a low predictive performance for risk of type 2 diabetes, irrespective of study design, participants' race/ethnicity, and the number of genetic markers included. Moreover, the addition of genome-wide association markers into conventional risk models produced little improvement in predictive performance.

Citing Articles

Proteomic Signature of BMI and Risk of Type 2 Diabetes.

Wang X, Ma H, Kou M, Heianza Y, Fonseca V, Qi L Diabetes. 2024; 74(2):234-242.

PMID: 39561322 PMC: 11755684. DOI: 10.2337/db24-0329.

Role of Delta/Notch-like EGF-related receptor in blood glucose homeostasis.

Ruiz-Otero N, Kuruvilla R Front Endocrinol (Lausanne). 2023; 14:1161085.

PMID: 37223028 PMC: 10200888. DOI: 10.3389/fendo.2023.1161085.

Multi-omics profiling: the way towards precision medicine in metabolic diseases.

Hu C, Jia W J Mol Cell Biol. 2021; .

PMID: 34406397 PMC: 8697344. DOI: 10.1093/jmcb/mjab051.

The association between plasma proneurotensin and glucose regulation is modified by country of birth.

Fawad A, Nilsson P, Struck J, Bergmann A, Melander O, Bennet L Sci Rep. 2019; 9(1):13640.

PMID: 31541150 PMC: 6754414. DOI: 10.1038/s41598-019-50040-3.

Genetic Privacy, Disease Prevention, and the Principle of Rescue.

Kilbride M Hastings Cent Rep. 2018; 48(3):10-17.

PMID: 29806892 PMC: 7012315. DOI: 10.1002/hast.849.

References

Stumvoll M, Goldstein B, van Haeften T . Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365(9467):1333-46. DOI: 10.1016/S0140-6736(05)61032-X. View

Jakobsdottir J, Gorin M, Conley Y, Ferrell R, Weeks D . Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet. 2009; 5(2):e1000337. PMC: 2629574. DOI: 10.1371/journal.pgen.1000337. View

Florez J, Jablonski K, Bayley N, Pollin T, de Bakker P, Shuldiner A . TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006; 355(3):241-50. PMC: 1762036. DOI: 10.1056/NEJMoa062418. View

Buijsse B, Simmons R, Griffin S, Schulze M . Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev. 2011; 33:46-62. PMC: 3132807. DOI: 10.1093/epirev/mxq019. View

van Hoek M, Dehghan A, Witteman J, Van Duijn C, Uitterlinden A, Oostra B . Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008; 57(11):3122-8. PMC: 2570410. DOI: 10.2337/db08-0425. View

Redon R, Ishikawa S, Fitch K, Feuk L, Perry G, Andrews T . Global variation in copy number in the human genome. Nature. 2006; 444(7118):444-54. PMC: 2669898. DOI: 10.1038/nature05329. View

Weedon M, McCarthy M, Hitman G, Walker M, Groves C, Zeggini E . Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006; 3(10):e374. PMC: 1584415. DOI: 10.1371/journal.pmed.0030374. View

Craddock N, Hurles M, Cardin N, Pearson R, Plagnol V, Robson S . Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010; 464(7289):713-20. PMC: 2892339. DOI: 10.1038/nature08979. View

Bonetta L . Getting up close and personal with your genome. Cell. 2008; 133(5):753-6. DOI: 10.1016/j.cell.2008.05.008. View

10.

Evans J, Berg J . Next-generation DNA sequencing, regulation, and the limits of paternalism: the next challenge. JAMA. 2011; 306(21):2376-7. DOI: 10.1001/jama.2011.1788. View

11.

Cauchi S, Meyre D, Durand E, Proenca C, Marre M, Hadjadj S . Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One. 2008; 3(5):e2031. PMC: 2346547. DOI: 10.1371/journal.pone.0002031. View

12.

Xu M, Bi Y, Xu Y, Yu B, Huang Y, Gu L . Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One. 2010; 5(11):e14022. PMC: 2984434. DOI: 10.1371/journal.pone.0014022. View

13.

Aschard H, Chen J, Cornelis M, Chibnik L, Karlson E, Kraft P . Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases. Am J Hum Genet. 2012; 90(6):962-72. PMC: 3370279. DOI: 10.1016/j.ajhg.2012.04.017. View

14.

Bonnefond A, Clement N, Fawcett K, Yengo L, Vaillant E, Guillaume J . Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012; 44(3):297-301. PMC: 3773908. DOI: 10.1038/ng.1053. View

15.

Noble D, Mathur R, Dent T, Meads C, Greenhalgh T . Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011; 343:d7163. PMC: 3225074. DOI: 10.1136/bmj.d7163. View

16.

Mihaescu R, van Hoek M, Sijbrands E, Uitterlinden A, Witteman J, Hofman A . Evaluation of risk prediction updates from commercial genome-wide scans. Genet Med. 2009; 11(8):588-94. DOI: 10.1097/GIM.0b013e3181b13a4f. View

17.

Li S, Zhao J, Luan J, Langenberg C, Luben R, Khaw K . Genetic predisposition to obesity leads to increased risk of type 2 diabetes. Diabetologia. 2011; 54(4):776-82. PMC: 3052481. DOI: 10.1007/s00125-011-2044-5. View

18.

Zimmet P, Alberti K, Shaw J . Global and societal implications of the diabetes epidemic. Nature. 2001; 414(6865):782-7. DOI: 10.1038/414782a. View

19.

Schulze M, Weikert C, Pischon T, Bergmann M, Al-Hasani H, Schleicher E . Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care. 2009; 32(11):2116-9. PMC: 2768223. DOI: 10.2337/dc09-0197. View

20.

Janssens A, Gwinn M, Bradley L, Oostra B, Van Duijn C, Khoury M . A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet. 2008; 82(3):593-9. PMC: 2427295. DOI: 10.1016/j.ajhg.2007.12.020. View